Clinical Trials Logo

IMAGE clinical trials

View clinical trials related to IMAGE.

Filter by:

NCT ID: NCT05134064 Completed - IMAGE Clinical Trials

68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer

Start date: December 1, 2020
Phase:
Study type: Observational

Dual-time point 68Ga-PSMA PET/CT could increase the lesion detection in PCa patients, it remains difficult to perform in clinical practice. The possibility of one-time point 68Ga-PSMA PET/CT imaging could be achieved using a total-body PET/CT.

NCT ID: NCT05043662 Recruiting - Clinical trials for Urothelial Carcinoma

UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.

Start date: September 1, 2021
Phase:
Study type: Observational

Upper tract urothelial carcinoma (UTUC) diagnosis include urography using computed tomography urography (CTU) or urography using MRI (MRU). The sensitivity of CTU decreases substan¬tially with decreasing lesion size. Other drawbacks of CTU include the radiation exposure and potential adverse effects in patients with allergic reactions or pre-existing renal impairment. In terms of urine cytology, the major drawbacks of urine cytology are low sensitivity and highly dependent of the experience and skills of the cytopathologist. We here intended to investigate whether UroCAD can be added in the diagnostic work-up of UTUC patient, and improve the accuracy of predicting UTUC before surgery.

NCT ID: NCT05004597 Completed - Development, Infant Clinical Trials

3D Craniofacial Morphologic Development of Healthy Infants

Start date: December 4, 2018
Phase: N/A
Study type: Interventional

Healthy infants were enrolled to receive three dimensional craniofacial photography regularly at their age of one month, two month, four month, six month, nine month and twelve month. All the image data was analyzed to reveal infants' craniofacial development.

NCT ID: NCT04689529 Active, not recruiting - Breast Cancer Clinical Trials

Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast Cancer

PUMP
Start date: March 23, 2018
Phase: N/A
Study type: Interventional

- The surgical method for breast cancer is determined according to the size and location of the remaining lesions after prior chemotherapy. - There are many patients who were able to undergo partial resection when confirming the final results of patients who underwent total resection after prior chemotherapy. - Therefore, we would like to investigate whether it is effective to make decisions based on the results of pre-operative tests after prior chemotherapy.

NCT ID: NCT04498611 Completed - Clinical trials for Invasive Breast Cancer

Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy

Start date: July 13, 2020
Phase: N/A
Study type: Interventional

It is considered that whether or not the accompanying invasive cancer classified through MRI images of breast cancer patients identified as Ductal Carcinoma in situ (DCIS) through preoperative tissue biopsy is significantly consistent with the postoperative stage. Therefore, this study intend to evaluate the effectiveness as a diagnostic tool that can help determine the axillary lymph node surgery by predicting the possibility of post-operative up-staging using magnetic resonance imagings of breast cancer patients who have been identified as ductal carcinoma in situ and are scheduled for surgery.